Daniela Di Lisi

1.0k total citations
59 papers, 607 citations indexed

About

Daniela Di Lisi is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Daniela Di Lisi has authored 59 papers receiving a total of 607 indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Cardiology and Cardiovascular Medicine, 14 papers in Molecular Biology and 13 papers in Oncology. Recurrent topics in Daniela Di Lisi's work include Chemotherapy-induced cardiotoxicity and mitigation (27 papers), Cardiovascular Function and Risk Factors (20 papers) and Cardiac Imaging and Diagnostics (13 papers). Daniela Di Lisi is often cited by papers focused on Chemotherapy-induced cardiotoxicity and mitigation (27 papers), Cardiovascular Function and Risk Factors (20 papers) and Cardiac Imaging and Diagnostics (13 papers). Daniela Di Lisi collaborates with scholars based in Italy, Spain and United States. Daniela Di Lisi's co-authors include Giuseppina Novo, Salvatore Novo, Concetta Zito, Rosalinda Madonna, Carlo G. Tocchetti, Cristina Madaudo, Antonio Russo, Francesca Bonura, Ines Monte and Christian Cadeddu Dessalvi and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Heart Journal and The American Journal of Cardiology.

In The Last Decade

Daniela Di Lisi

50 papers receiving 603 citations

Peers

Daniela Di Lisi
Raluca Mincu Germany
Carrie G. Lenneman United States
Iyad N. Daher United States
Rupal O’Quinn United States
Jacek Bil Poland
Mary T. Vooletich United States
Hannah Gilman United States
Raluca Mincu Germany
Daniela Di Lisi
Citations per year, relative to Daniela Di Lisi Daniela Di Lisi (= 1×) peers Raluca Mincu

Countries citing papers authored by Daniela Di Lisi

Since Specialization
Citations

This map shows the geographic impact of Daniela Di Lisi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniela Di Lisi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniela Di Lisi more than expected).

Fields of papers citing papers by Daniela Di Lisi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daniela Di Lisi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniela Di Lisi. The network helps show where Daniela Di Lisi may publish in the future.

Co-authorship network of co-authors of Daniela Di Lisi

This figure shows the co-authorship network connecting the top 25 collaborators of Daniela Di Lisi. A scholar is included among the top collaborators of Daniela Di Lisi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daniela Di Lisi. Daniela Di Lisi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Madaudo, Cristina, Antonio Cannatà, Pietro Ameri, et al.. (2025). Effects of sodium–glucose cotransporter 2 inhibitors in patients with cancer and diabetes mellitus: a systematic review and meta-analysis. European Heart Journal - Cardiovascular Pharmacotherapy. 11(4). 343–352. 2 indexed citations
2.
Madaudo, Cristina, Vincenzo Nuzzi, Paolo Manca, et al.. (2025). Biomarkers for Congestion in Heart Failure: State-of-the-art and Future Directions. Cardiac failure review. 11. e01–e01.
3.
Deidda, Martino, Cristina Madaudo, Vincenzo Quagliariello, et al.. (2025). Genetic Background in Patients with Cancer Therapy-Induced Cardiomyopathy. Journal of Clinical Medicine. 14(4). 1286–1286. 3 indexed citations
4.
Lisi, Daniela Di, et al.. (2024). Myocarditis prognostic score: a new risk assessment tool in patients with myocarditis. European Heart Journal. 45(Supplement_1).
5.
Tricarico, Lucia, Daniela Di Lisi, Giuseppe Armentaro, et al.. (2024). Cardiovascular Biomarkers in Cardio-Oncology: Antineoplastic Drug Cardiotoxicity and Beyond. Biomolecules. 14(2). 199–199. 5 indexed citations
6.
Lisi, Daniela Di, Antonella Moreo, Grazia Casavecchia, et al.. (2023). Atrial Strain Assessment for the Early Detection of Cancer Therapy-Related Cardiac Dysfunction in Breast Cancer Women (The STRANO STUDY: Atrial Strain in Cardio-Oncology). Journal of Clinical Medicine. 12(22). 7127–7127. 14 indexed citations
7.
Lisi, Daniela Di, Cristina Madaudo, Clarissa Filorizzo, et al.. (2023). Chemotherapy-related cardiac dysfunction: the usefulness of myocardial work indices. The International Journal of Cardiovascular Imaging. 39(10). 1845–1853. 11 indexed citations
8.
Lisi, Daniela Di, Christian Cadeddu Dessalvi, Concetta Zito, et al.. (2023). Management of cancer patients at high and very-high risk of cardiotoxicity: Main questions and answers. Current Problems in Cardiology. 49(3). 102229–102229. 3 indexed citations
9.
Lisi, Daniela Di, et al.. (2022). The New HFA/ICOS Risk Assessment Tool to Identify Patients with Chronic Myeloid Leukaemia at High Risk of Cardiotoxicity. ESC Heart Failure. 9(3). 1914–1919. 25 indexed citations
10.
Lisi, Daniela Di, et al.. (2022). Therapy of ATTR Cardiac Amyloidosis: Current Indications. Current Problems in Cardiology. 48(2). 101487–101487. 13 indexed citations
11.
Filorizzo, Clarissa, Daniele Fanale, Chiara Brando, et al.. (2021). Role of the HIPPO pathway as potential key player in the cross talk between oncology and cardiology. Critical Reviews in Oncology/Hematology. 159. 103246–103246. 2 indexed citations
12.
Lisi, Daniela Di, et al.. (2021). Subclinical Cardiotoxicity: The Emerging Role of Myocardial Work and Other Imaging Techniques. Current Problems in Cardiology. 46(6). 100818–100818. 18 indexed citations
14.
Novo, Giuseppina, Ciro Santoro, Daniela Di Lisi, et al.. (2020). Usefulness of Stress Echocardiography in the Management of Patients Treated with Anticancer Drugs. Journal of the American Society of Echocardiography. 34(2). 107–116. 19 indexed citations
15.
Tocchetti, Carlo G., Christian Cadeddu Dessalvi, Daniela Di Lisi, et al.. (2017). From Molecular Mechanisms to Clinical Management of Antineoplastic Drug-Induced Cardiovascular Toxicity: A Translational Overview. Antioxidants and Redox Signaling. 30(18). 2110–2153. 89 indexed citations
16.
Lisi, Daniela Di, Rosalinda Madonna, Concetta Zito, et al.. (2016). Anticancer therapy-induced vascular toxicity: VEGF inhibition and beyond. International Journal of Cardiology. 227. 11–17. 54 indexed citations
17.
Lisi, Daniela Di, Giuseppe Vitale, Riccardo M. Inciardi, et al.. (2014). Chemotherapy cardiotoxicity. Journal of Cardiovascular Medicine. 17(4). 270–275. 16 indexed citations
18.
Dendramis, Gregory, et al.. (2014). Large left ventricular metastasis in patient with liposarcoma. Journal of Cardiovascular Medicine. 17. e166–e168. 2 indexed citations
19.
Lisi, Daniela Di, Egle Corrado, Francesca Bonura, et al.. (2013). Profilo di rischio cardiovascolare nei pazienti con psoriasi. Recenti Progressi in Medicina. 104(3). 102–5. 5 indexed citations
20.
Lisi, Daniela Di, et al.. (2011). Chemotherapy-induced cardiotoxicity. Anti-Cancer Drugs. 22(5). 468–472. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026